- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.38 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x AGS: PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER(Non-covalent)
- 6 x 2VJ: 2-[(2-{(1S,2S)-2-[(3,4-dichlorobenzyl)carbamoyl]cyclohexyl}-6-ethylpyrimidin-4-yl)sulfanyl]-1H-imidazole-5-carboxylic acid(Non-covalent)
2VJ.2: 17 residues within 4Å:- Chain A: I.132, E.135, V.136, Y.139
- Chain C: P.9, C.36, V.37, L.38, K.43, G.73, L.74, L.75, R.89, Y.99, E.100, M.106, N.107
11 PLIP interactions:8 interactions with chain C, 3 interactions with chain A- Hydrophobic interactions: C:P.9, C:L.74, C:L.75, C:L.75, C:R.89, A:I.132, A:V.136
- Hydrogen bonds: C:L.75, C:N.107, A:E.135
- Halogen bonds: C:C.36
2VJ.3: 18 residues within 4Å:- Chain A: P.9, G.10, S.11, C.36, V.37, L.38, F.71, G.73, L.74, L.75, R.89, Y.99, L.103, M.106, N.107
- Chain B: E.135, Y.139
- Ligands: AGS.1
12 PLIP interactions:11 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:P.9, A:L.74, A:L.75, A:L.103, A:M.106
- Hydrogen bonds: A:S.11, A:L.75, A:R.89, A:Y.99, A:N.107, B:E.135
- Halogen bonds: A:C.36
2VJ.5: 18 residues within 4Å:- Chain B: P.9, G.10, C.36, V.37, L.38, F.71, G.73, L.74, L.75, R.89, Y.99, E.100, L.103, M.106, N.107
- Chain C: E.135, V.136, Y.139
14 PLIP interactions:3 interactions with chain C, 11 interactions with chain B- Hydrophobic interactions: C:V.136, B:P.9, B:L.38, B:L.74, B:L.75, B:L.103
- Hydrogen bonds: C:E.135, C:E.135, B:L.75, B:Y.99, B:Y.99
- Water bridges: B:N.107
- Halogen bonds: B:C.36, B:C.36
2VJ.8: 18 residues within 4Å:- Chain D: P.9, G.10, C.36, V.37, L.38, G.73, L.74, L.75, R.89, Y.99, E.100, L.103, M.106, N.107, L.110
- Chain E: E.135, V.136, Y.139
16 PLIP interactions:13 interactions with chain D, 3 interactions with chain E- Hydrophobic interactions: D:L.74, D:L.75, D:L.75, D:L.75, D:L.103, D:L.103, D:M.106, D:L.110, E:V.136
- Hydrogen bonds: D:L.75, D:Y.99, D:Y.99, D:N.107, E:E.135, E:E.135
- Halogen bonds: D:C.36
2VJ.11: 16 residues within 4Å:- Chain E: P.9, G.10, C.36, V.37, G.73, L.74, L.75, R.89, Y.99, E.100, L.103, M.106, N.107
- Chain F: E.135, V.136, Y.139
9 PLIP interactions:7 interactions with chain E, 2 interactions with chain F- Hydrophobic interactions: E:L.74, E:L.75, E:L.75, E:L.103, F:V.136
- Hydrogen bonds: E:L.75, E:N.107, F:E.135
- Halogen bonds: E:C.36
2VJ.12: 16 residues within 4Å:- Chain D: E.135, V.136, Y.139
- Chain F: P.9, G.10, C.36, V.37, L.38, G.73, L.74, L.75, R.89, Y.99, E.100, M.106, N.107
12 PLIP interactions:10 interactions with chain F, 2 interactions with chain D- Hydrophobic interactions: F:P.9, F:L.38, F:L.74, F:L.75, D:V.136
- Hydrogen bonds: F:L.75, F:Y.99, F:N.107, D:Y.139
- Water bridges: F:V.76
- Salt bridges: F:K.43
- Halogen bonds: F:C.36
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- de Jonge, B.L. et al., Discovery of inhibitors of 4'-phosphopantetheine adenylyltransferase (PPAT) to validate PPAT as a target for antibacterial therapy. Antimicrob.Agents Chemother. (2013)
- Release Date
- 2014-03-12
- Peptides
- Phosphopantetheine adenylyltransferase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.38 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x AGS: PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER(Non-covalent)
- 6 x 2VJ: 2-[(2-{(1S,2S)-2-[(3,4-dichlorobenzyl)carbamoyl]cyclohexyl}-6-ethylpyrimidin-4-yl)sulfanyl]-1H-imidazole-5-carboxylic acid(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- de Jonge, B.L. et al., Discovery of inhibitors of 4'-phosphopantetheine adenylyltransferase (PPAT) to validate PPAT as a target for antibacterial therapy. Antimicrob.Agents Chemother. (2013)
- Release Date
- 2014-03-12
- Peptides
- Phosphopantetheine adenylyltransferase: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F